« Back
Comparison of cfDNA Reference Material Prepared using Enzymatic Fragmentation or Sonication for the Validation of Liquid Biopsy Assays
Poster Title: Comparison of cfDNA Reference Material Prepared using Enzymatic Fragmentation or Sonication for the Validation of Liquid Biopsy Assays
Submitted on 05 Nov 2018
Author(s): Hannah Child, Aldo Mele, Katarzyna Wilczynska, Julie Wickenden
Affiliations: Horizon Discovery Group
This poster was presented at AMP Annual Meeting 2018
Poster Views: 774
View poster »

Poster Information
Abstract: The genotype of multiple actionable loci can now be determined from as little as 10ng DNA extracted from a routine patient blood sample, helping to direct therapeutic decision making and improve overall clinical outcome faster for the patient. However, in order to realise the full potential of this emerging technology, sequencing labs need to ensure accuracy by validating a range of challenging new techniques. This includes the ability to extract cfDNA from blood samples, sequence it at new levels of sensitivity (down to 0.1% limit of detection) and establish effective bioinformatics pipelines. Reference materials that closely mimic real cfDNA samples are critical to support this effort. This study investigates the use of sonicated or enzymatically sheared cell-line derived DNA as alternative methods to create the most commutable cfDNA reference material for the validation of liquid biopsy assays. Methods: DNA was extracted from well-characterised cancer cell lines and fragmented to 160bp using either sonication or enzymatic shearing, as assessed by Tapestation. In addition, a size selection step was included for investigation into the ability to purity the fragment peak to a size distribution profile most similar to real cfDNA samples. Test samples were validated for the presence of 8 onco-relevant mutations by ddPCR, allowing for accurate variant allele frequency to be determined. The sample set was tested by NGS on Thermo breast cfDNA assay, and Illumina TST-15 assay, following the manufacturer’s instructions. Results: Tapestation analysis confirmed that both sonication and enzymatic shearing produced cfDNA with an average fragment size of 160-170bp. A size selection step proved useful to concentrate the amount of DNA within the desired fragment size range. Variant detection by ddPCR confirmed the presence of 8 mutations across 4 genes (EGFR, KRAS, NRAS and PIK3CA) at either 0.1% or 5% variant allele frequency. Analysis by NGS confirmed that all variants were detectable at the correct allele frequency as expected. Conclusion: Results demonstrate that both sonication and enzymatic shearing can be used to create cfDNA reference material with an average fragment size of 160-170bp to closely mimic cfDNA from real patient samples. This study has allowed a new manufacturing method to be investigated,utilising enzymatic shearing and a size selection step in order to further improve the commutability of high quality cell-line derived cfDNA reference material for the validation of liquid biopsy assays.Summary: The growing field of liquid biopsies has huge potential to transform the clinical oncology space; allowing more genetic tests to be carried out on smaller amounts of tumour DNA without the need for invasive deep-tissue surgical biopsies. References: Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Bleeding Pseudoaneurysm in uncommon locations: interesting cases
Dr Joel James (SHO), Dr Chandni Patel (SpR) & Dr Shirish Prabhudesai (Consultant)

Diagnostic outcomes of MRE as an investigation for NSS of small bowel disease: Can CTE be a cost-effective alternative in patients above 50 years old?
K ElGendy, E Musgrave, M Twemlow

Appropriateness of MRCP use in a DGH
A Elawad, B Billimoria

Kashtwari D*, Alamoudi. A

Evaluation of the first 18 months of the ‘Abnormal GP Chest X-ray Straight to CT’ Pathway at Princess Alexandra Hospital (Harlow, Essex)
James K. Diss, Tamer Adem, Mark Gregory, Elena Stefan, Vijay Jayaram, Sridhar Redla, Sandra Dimmock